IntellxxDNA

Curated by Signal

Provider of clinical decision platform based on patient's genomic data

Overview

IntellxxDNA provides a clinical decision platform for practitioners based on their patient's genomic data. The intelligence platform helps healthcare professionals to manage their treatment plans, reduce health risks and more based on the analysis of the gene function and drug reactions on the patient's genomic profile. The patient's samples are collected and processed for genomic analysis via IntellxxDNA test kit.

Key facts

Founded: 2018
Headquarters: Austin, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

3 products and services: Sign up to view
Commercial model: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

OneTest
Developer of AI-based diagnostic test for multiple cancer
Life Sciences TechnologyRockville, United States
Alert 1
Developer of emergency medical alert systems for senior care
Life Sciences TechnologyWilliamsport, United States
Datomics Group
Provider of a market intelligence platform that leverages AI to provide insights for biotech companies
Life Sciences TechnologySan Mateo, United States

About IntellxxDNA

What does IntellxxDNA do?

IntellxxDNA provides a clinical decision platform for practitioners based on their patient's genomic data.

Where is IntellxxDNA headquartered?

IntellxxDNA is headquartered in Austin, United States.

When was IntellxxDNA founded?

IntellxxDNA was founded in 2018.

Which sector is IntellxxDNA in?

IntellxxDNA operates in Life Sciences Technology.

Who are IntellxxDNA's competitors?

Companies similar to IntellxxDNA include OneTest, Alert 1, and Datomics Group.